Advertisement

Phenoxybenzamine is no longer the standard agent used for alpha blockade before adrenalectomy for pheochromocytoma: A national study of 552 patients

Published:September 24, 2022DOI:https://doi.org/10.1016/j.surg.2022.05.039

      Abstract

      Background

      Phenoxybenzamine has been the standard agent for blockade before adrenalectomy for pheochromocytoma. However, high cost and limited availability have hampered its use. This study investigated whether other agents have supplanted the use of phenoxybenzamine as the first-line agent for alpha blockade in pheochromocytoma.

      Methods

      We performed a retrospective analysis of patients in the IBM MarketScan Database who underwent adrenalectomy for pheochromocytoma (2008–2019). Patients were categorized as having been blocked with phenoxybenzamine, selective alpha blockers, calcium channel blockers and/or beta blockers, or none of the above. The outcomes included prescription costs, perioperative costs, and length of stay.

      Results

      A total of 552 patients were identified; 58.7% were female, and the median age was 49 (interquartile range 40–57) years. In total, 291 (52.7%) patients were blocked with phenoxybenzamine, 114 (20.7%) with selective alpha blockers, 42 (7.6%) with only calcium channel blockers and/or beta blockers, and 76 (13.8%) with none. The proportion of patients blocked with phenoxybenzamine decreased from 71.0% in 2008 to 21.2% in 2019. The proportion of patients blocked with selective alpha blockers increased from 6.5% in 2008 to 42.4% and in 2019. The median cost of phenoxybenzamine increased from $722 (interquartile range $441–$1,514) in 2008 to $9,616 (interquartile range $5,049–$16,373) in 2019 (P < .001). Length of stay (2 [interquartile range 1–4] days vs 2 [interquartile range 0–3] days) and total perioperative costs ($24,250 [interquartile range $17,462–$33,849] vs $22,098 [interquartile range $16,341–$29,178] between phenoxybenzamine and selective alpha blocker groups were similar.

      Conclusion

      There has been a significant shift away from phenoxybenzamine for preoperative blockade before resection of pheochromocytoma. Selective alpha blockers and calcium channel blockers are increasingly used, likely due to reduced costs, without compromised length of stay or intensive care unit admission.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Grimson K.S.
        Treatment of a patient with a pheochromocytoma: use of an adrenolytic drug before and during operation.
        J Am Med Assoc. 1949; 140: 1273-1274
        • Brunaud L.
        • Boutami M.
        • Nguyen-Thi P.L.
        • et al.
        Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma.
        Surgery. 2014; 156: 1410-1418
        • Kiernan C.M.
        • Du L.
        • Chen X.
        • et al.
        Predictors of hemodynamic instability during surgery for pheochromocytoma.
        Ann Surg Oncol. 2014; 21 (3865–3865)
        • Prys-Roberts C.
        • Farndon J.R.
        Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.
        World J Surg. 2002; 26: 1037-1042
        • Randle R.W.
        • Balentine C.J.
        • Pitt S.C.
        • Schneider D.F.
        • Sippel R.S.
        Selective versus non-selective alpha-blockade prior to laparoscopic adrenalectomy for pheochromocytoma.
        Ann Surg Oncol. 2017; 24 (244–244)
        • Scholten A.
        • Cisco R.M.
        • Vriens M.R.
        • Shen W.T.
        • Duh Q.Y.
        Variant adrenal venous anatomy in 546 laparoscopic adrenalectomies.
        JAMA Surg. 2013; 148: 378-383
        • Buitenwerf E.
        • Osinga T.E.
        • Timmers H.J.L.M.
        • et al.
        Efficacy of α-blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial.
        J Clin Endocrinol Metab. 2020; 105: 2381
        • Groeben H.
        • Nottebaum B.J.
        • Alesina P.F.
        • Traut A.
        • Neumann H.P.
        • Walz M.K.
        Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series.
        Br J Anaesth. 2017; 118: 182-189
        • Schimmack S.
        • Kaiser J.
        • Probst P.
        • Kalkum E.
        • Diener M.K.
        • Strobel O.
        Meta-analysis of α-blockade versus no blockade before adrenalectomy for phaeochromocytoma.
        Br J Surg. 2020; 107: e102-e108
        • Lenders J.W.M.
        • Duh Q.-Y.
        • Eisenhofer G.
        • et al.
        Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
        J Clin Endocrinol Metab. 2014; 99: 1915-1942
        • Patel D.
        • Phay J.E.
        • Yen T.W.F.
        • et al.
        Update on pheochromocytoma and paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, part 2 of 2: perioperative management and outcomes of pheochromocytoma and paraganglioma.
        Ann Surg Oncol. 2020; 27 (1338–1338)
      1. IBM Marketscan Research Databases. Accessed 2022 January 8, 2022. Available at: https://www.ibm.com/products/marketscan-research-databases/databases

      2. CPI Inflation Calculator. Accessed October 22, 2022. Available at: https://www.bls.gov/data/inflation_calculator.htm

        • Wunsch H.
        • Kramer A.
        • Gershengorn H.B.
        Validation of intensive care and mechanical ventilation codes in Medicare data.
        Crit Care Med. 2017; 45: e711
        • Morgan S.G.
        • Bathula H.S.
        • Moon S.
        Pricing of pharmaceuticals is becoming a major challenge for health systems.
        BMJ. 2020; 368
        • Fralick M.
        • Kesselheim A.S.
        The U.S. insulin crisis: rationing a lifesaving medication discovered in the 1920s.
        N Engl J Med. 2019; 381: 1793-1795
      3. National Drug Code Directory. Accessed September 19, 2021. Available at: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm

        • Kulaylat A.S.
        • Schaefer E.W.
        • Messaris E.
        • Hollenbeak C.S.
        Truven Health Analytics MarketScan Databases for clinical research in colon and rectal surgery.
        Clin Colon Rectal Surg. 2019; 32: 54-60
        • Ferver K.
        • Burton B.
        • Jesilow P.
        The use of claims data in healthcare research.
        Open Public Health J. 2009; 2: 11-24